Loyola University Clinical Trials
Sponsors / Loyola University
102 ClinicalTrials.gov entries name Loyola University as the lead sponsor. Of these, 11 are recruiting, 5 are active without new recruitment, and 56 have completed. The registry records 10 terminated or withdrawn trials for Loyola University. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. Planned participant enrollment across these trials sums to 22,888. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
102
Total Trials
11
Recruiting
5
Other Active
56
Completed
10
Terminated / Withdrawn
22,888
Total Enrollment
Termination reasons: Recruitment40% · Other30% · Funding20% · PI/or_Site10%
Recent Terminations
- Prostate Cancer - Recurrent"The study was stopped for feasibility"
- Acute Lymphocytic Leukemia"Poor accrual"
- Bleed Pregnancy"PI left Loyola and Sub-I graduated."
- Fusion of Spine"The study was terminated by the Institutional Review Board."
- Diabetes"the study was halted prematurely due to slow recruitment and expiration of funding"
- Tibial Fractures"The study was stopped for feasibility (low enrollment)"
- Hodgkin's Lymphoma"There was lack of enrollment since January 2013"
- Osteomyelitis"The study was stopped for feasibility (i.e., low recruitment)"
- Burn Pain"No funding source."
- Cesarean Section"Change in treatment plan for this population terminated the project"
Active Trials (5 total)
- Erectile Dysfunction EARLY_PHASE1NCT05100654
- Neurogenic Bladder EARLY_PHASE1NCT07308808
- Abscess PHASE4NCT06284473
- NCT03312972
- Overactive Bladder PHASE4NCT05557279
- NCT05728957
- NCT05750212
- Pain, Postoperative PHASE4NCT05824832
- NCT05554081
- NCT06619301
- NCT04276792
- NCT03378765
- Analgesics, Opioid PHASE4NCT05985629
- Shingles PHASE2NCT05554068
- Melanoma PHASE1NCT01586403
- Melanoma PHASE1NCT02870244